Kristina Lend

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2020

Collaborators (11)

Per-Johan Jakobson

Professor

Karolinska Institutet

SWEDEN

View details

Merete Lund Hetland

Professor

University of Copenhagen

DENMARK

View details

Anna-Karin Ekwall

Associate senior lecturer

University of Gothenburg

SWEDEN

View details

Giovanni Cagnotto

Lund University

SWEDEN

View details

Jianyang Liu

Karolinska Institutet

SWEDEN

View details

Mikkel Østergaard

Professor

Rigshospitalet

DENMARK

View details

Francesca Faustini

Karolinska Institutet

SWEDEN

View details

Ronald van Vollenhoven

Professor and Chief

Amsterdam UMC

NETHERLANDS

View details

Line Uhrenholt

Aalborg University

DENMARK

View details

Hanne Merete Lindegaard

University of Southern Denmark

DENMARK

View details

Leonid Padyukov

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kristina Lend

Research Interests

Explore related searches

Contact this professor

Articles (7)

Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.

Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial.

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Collaborators (11)

Per-Johan Jakobson

Merete Lund Hetland

Anna-Karin Ekwall

Giovanni Cagnotto

Jianyang Liu

Mikkel Østergaard

Francesca Faustini

Ronald van Vollenhoven

Line Uhrenholt

Hanne Merete Lindegaard

Leonid Padyukov

Make your next move.